HRSA Office of Pharmacy Affairs (OPA)
has a process for registering covered entities who choose to
participate in the section 340B Drug Pricing Program. These
entities must comply with the requirements of 340B (a)(5)(A) of the
PHS Act. The 340B Drug Pricing Program forms allow entities to
provide registration and certifying information and to determine
eligibility for the progam.
A portion of the increase is
associated with the implementation of provisions of section 340B of
the Public Health Service Act that were amended by sections 7101
and 7102 of the Affordable Care Act. This includes an expansion of
eligible entities for the program under section 340B(a)(4) to
include the addition of Free Standing Cancer Hospitals, Critical
Access Hospitals (CAH), Rural Referral Centers (RRC) and Sole
Community Hospitals (SCH). The amended statute also includes new
covered entity compliance provisions in section 340B(a)(2)
requiring the Secretary to adopt integrity provisions to improve
oversight of program compliance, enable covered entities to
regularly update information on the 340B website, and to verify
information on the website.
$101,004
No
No
Yes
No
No
Uncollected
Jodi Duckhorn 301
443-1984
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.